Compare FOF & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOF | FBRX |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 371.4M | 379.3M |
| IPO Year | N/A | 2017 |
| Metric | FOF | FBRX |
|---|---|---|
| Price | $13.42 | $26.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $67.00 |
| AVG Volume (30 Days) | 75.9K | ★ 172.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 9.07% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.97 | $4.91 |
| 52 Week High | $15.04 | $35.62 |
| Indicator | FOF | FBRX |
|---|---|---|
| Relative Strength Index (RSI) | 33.64 | 39.92 |
| Support Level | $12.87 | $26.67 |
| Resistance Level | $14.50 | $32.40 |
| Average True Range (ATR) | 0.21 | 2.39 |
| MACD | -0.12 | -0.39 |
| Stochastic Oscillator | 8.04 | 11.12 |
Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. The Fund's investment objective is to achieve total return, consisting of high current income and potential capital appreciation.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).